THE MEASUREMENT OF TRIGLYCERIDE IN BRAIN AND THE METABOLISM OF BRAIN TRIGLYCERIDE IN VITRO

Abstract—

• 1 Triglyceride has been isolated from brain by thin-layer chromatography and determined by absorption of the carbonyl group at 1740 cm^?1. The means of yields from whole mouse brain, whole rat brain, rat brain grey matter, rat brain stem, and incubated slices of rat brain cortex were 0.15–0.17 μmole/g tissue.
• 2 The distribution of fatty esters varied from preparation to preparation. Palmitate, stearate and oleate usually occurred in greatest amounts. Hydrolysis of a preparation of triglyceride from whole rat brain with pancreatic lipase indicated that palmitate was equally distributed between the α and β esters.
• 3 [1-¹⁴C]Acetate was rapidly incorporated into triglyceride of slices of incubated rat brain cortex. When the resulting triglyceride was hydrolysed with pancreatic lipase the distribution of radioactivity amongst the hydrolysis products was consistent with both the α and β esters of the triglyceride having been radioactively labelled.

     

FATE OF l-GLUTAMATE IN THE BRAIN

Abstract— It is shown, using aminooxyacetate as metabolic inhibitor, that the process of oxidation of endogenous glutamate in incubated rat brain cortex slices follows a different course from that of exogenous l -glutamate. Whereas endogenous glutamate is largely oxidized by an initial reaction with glutamate dehydrogenase with release of ammonia, exogenous l -glutamate undergoes initial transamination to aspartate and α-oxoglutarate before oxidation occurs. In the presence of 2·5 m m l -glutamate, it is found that, of the total exogenous glutamate utilized, 49 per cent is converted to aspartate, 37 per cent is converted to glutamine and the rest is f uily oxidized through glutamate dehydrogenase. It is suggested that endogenous glutamate is normally oxidized in the neurons, and that glutamate released from neurons during excitation, and acting therefore as exogenous glutamate, is taken up by the glia where, besides conversion to glutamine, it largely undergoes initial transamination before oxidation takes place.     

TRIPHOSPHOINOSITIDE PHOSPHODIESTERASE IN DEVELOPING BRAIN OF THE RAT AND IN SUBCELLULAR FRACTIONS OF BRAIN

Abstract— An assay system for the measurement of triphosphoinositide phosphodiesterase in homogenates of rat brain is described. With triphosphoinositide (TPI) as substrate, and in the presence of 0·1 m -KCI and saturating amounts of diethyl ether, the activity of phosphodiesterase in myelinated brain was 400–500 μmoles of TPI hydrolysed per g wet wt. per hr. One quarter of the adult level of the enzyme was present in rat brain one day after birth, with the remainder being added prior to and during the early stages of myelination. On subfractionation of brain homogenates, substantial activity of the enzyme was located in the soluble portion and in the paniculate fractions enriched in myelin and synaptosomes. The enzyme associated with the particulate fractions could not be detached from the membranes by any of several methods employed. There was a rough correlation between distribution of phosphodiesterase and that of 5'-nucleotidase, an enzyme associated with plasma membrane in a number of tissues. Some implications of the results are discussed.     

THE REGULATION OF PYRUVATE DEHYDROGENASE IN BRAIN IN VIVO

—The activity of pyruvate dehydrogenase in the brains of mice frozen in liquid nitrogen was 14·0 nmol/min per mg protein. It rose to 23·8 nmol/min per mg protein after incubation of the brain homogenate with 10mm -MgCl₂ to activate (dephosphorylate) the enzyme, indicating that approx 60% of the enzyme was originally in the active form. Treatment with amobarbital or pentobarbital halved the proportion of pyruvate dehydrogenase in the active form. The proportion of pyruvate dehydrogenase in the active form increased during ischemia, activation being complete within one min. Anesthesia with amobarbital slowed the activation during ischemia but did not alter the total amount of pyruvate dehydrogenase activity. The concentration of ATP, the ATP/ADP ratio and the adenylate energy charge increased as the proportion of pyruvate dehydrogenase in the active form decreased during barbiturate anesthesia, and they decreased as the proportion of pyruvate dehydrogenase in the active form increased during ischemia. After treatment with insulin, the proportion of pyruvate dehydrogenase in the active form increased by 30%. but the energy charge did not change. Treatment of mice with ether, morphine, ethanol, or diazepam did not change the proportion of pyruvate dehydrogenase in the active form although these treatments have been reported to alter pyruvate oxidation in brain in vivo. Treatments which altered pyruvate oxidation in the brain did not consistently alter the proportion of pyruvate dehydrogenase in the active form, unless they also altered energy charge.     

MECHANISMS ACTIVATING GLYCOLYSIS IN THE BRAIN IN ARTERIAL HYPOXIA

Abstract— In order to study regulatory steps responsible for the activation of anaerobic glycolysis in the brain during hypoxia, cerebral concentrations of carbohydrate substrates and organic phosphates were measured in rats after reduction of the arterial P_O2 to 23-25 mm Hg for 2, 5 and 15 min. The results demonstrated a progressive accumulation of lactate as well as of pyruvate and malate in the absence of changes in ATP, A DP, AMP, citrate and ammonia. The pattern of substrate changes obtained indicate that hypoxia is accompanied by activation of pyruvate kinase and of hexokinase, but not of phosphofructokinase. There was a progressive fall in intracellular pH and a moderate increase in the calculated cytoplasmic NADH/NAD⁺ ratio. The changes in pyruvate and in the NADH/NAD⁺ ratio may be responsible for the observed increase in the malate concentration.     

THE LOCALIZATION OF ENZYME ACTIVITIES IN THE RAT BRAIN

Studies with rat brain illustrate the usefulness of formol-calcium-fixed tissue for studying both enzymatic "chemoarchitectonics" and intracellular organelles. Unembedded frozen sections and polyvinyl alcohol-embedded sections may be used to demonstrate the activities of DPNH-tetrazolium reductase localized in mitochondria and ergastoplasm, TPNH-tetrazolium reductase localized in mitochondria, ATPase (and/or apyrase or ADPase) in cell membranes, and acid phosphatase in lysosomes.¹ Among the observations recorded are: (1) the presence of lysosomes in all cells of the brain; (2) the presence of numerous large lysosomes near the nuclei of capillary endothelial cells; (3) a polarized arrangement of large lysosomes in epithelial cells of the ependyma and choroid plexus; (4) the presence of ATPase activity in the cell membranes of some neurons; (5) the presence of either an apyrase or combination of ATPase and ADPase in the cell membranes of neuroglia and capillaries; (6) the presence of both DPNH- and TPNH-tetrazolium reductase activities in neuroglia; (7) the presence of DPNH- and TPNH-tetrazolium reductase activities in mitochondria and of DPNH-tetrazolium reductase activity in Nissl substance. The possible functional significance of these localizations is briefly discussed, as is their relation to "quantitative histochemistry" data available in the literature.     

THE ACTIVITY OF GANGLIOSIDE SIALIDASE IN THE DEVELOPING HUMAN BRAIN

—The development of ganglioside sialidase and of four different p-nitrophenyl glycosidases in human brain was investigated including both prenatal and postnatal periods. The developmental curve for sialidase was different from that of the other glycosidases. While p-nitrophenyl glycosidases showed high activities at an early stage of development (21 foetal weeks), and remained at about the same level, ganglioside sialidase was not detected before the foetal age of 15-20 weeks. The sialidase activity at term reached about half the adult level and there was a possible decrease in activity during the first year. The sialidase activity then increased, approaching the adult level at about the age of 5 years. The development of the ganglioside sialidase activity in human brain can be related to changes in the concentration of individual brain ganglioside components. The late maturation of the sialidase system in relation to other glycohydrolases is also discussed as a possible protective mechanism for sialic acid-containing compounds during the early period of development.     

OCCURRENCE OF N-ACETYL-l-GLUTAMIC ACID IN THE HUMAN BRAIN

A substance apparently identical with N-acetyl-l -glutamic acid was isolated from an aqueous extract from human brain by a combination of paper and ion exchange chromatography. The isolated substance does not react with ninhydrin reagent but yields glutamic acid upon acid hydrolysis. Acetyl hydrazide was identified by paper chromatography of hydrazinolysates of the isolated substance and N-acetyl-l -glutamic acid. The configuration was determined with l -specific hog kidney acylase.     

家兔中枢内源性阿片样物质在紧张性高血糖反应中的作用

本工作观察家兔内源性阿片样物质在紧张性高血糖反应中的作用。通过向家兔侧脑室内注射阿片受体阻断剂纳洛酮或羧基肽酶 A 的抑制剂 D-苯丙氨酸以分别减弱或加强脑内内源性阿片样物质的作用。结果表明,纳洛酮能使由乙醚或2-脱氧葡萄糖所引起的高血糖反应减弱,而使由胰岛素所引起的低血糖反应加强并延搁其回复过程。D-苯丙氨酸表现为相反的效应。在已对吗啡形成耐受的家兔,2-脱氧葡萄糖所引起的高血糖反应也呈减弱。这些结果提示,脑内内源性阿片样物质与紧张性高血糖反应有关。